@misc{indiciae54ed96c5dc3b,
  title = {GPR183 mediates the capacity of the novel CD47-CD19 bispecific antibody TG-1801 to heighten ublituximab-umbralisib (U2) anti-lymphoma activity},
  author = {Ribeiro, M. and Profitos-Peleja, N. and Santos, J. C. and Blecua, P. and Reyes Garau, D. and Armengol, M. and Fernandez-Serrano, M. and Miskin, H. P. and Bosch, F. and Esteller, M. and Normant, E. and Roue, G.},
  year = {2022},
  doi = {10.1101/2022.03.31.486558},
  url = {https://www.biorxiv.org/content/10.1101/2022.03.31.486558v1},
  note = {Source identifier: 10.1101/2022.03.31.486558}
}